Investigating a new genetic variant linked to preeclampsia
Novel NF-kB variant in preeclampsia
This study is looking at a new version of a gene that might play a role in preeclampsia, a serious condition during pregnancy, by using advanced gene-editing techniques and focusing on women in Bolivia, to see how it affects blood flow and the health of the placenta.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10809507 on NIH RePORTER |
What this research studies
This research focuses on understanding how a novel variant of the NF-kB gene may contribute to preeclampsia, a serious pregnancy complication. By using CRISPR gene-editing techniques and studying a population in Bolivia, where preeclampsia is more common, the researchers aim to uncover the role of this genetic variant in inflammatory responses during pregnancy. The study will involve physiological assessments to determine how this variant affects blood flow and placental health, which are critical for a healthy pregnancy.
Who could benefit from this research
Good fit: Ideal candidates for this research include pregnant women, particularly those from high-altitude regions or with a family history of preeclampsia.
Not a fit: Patients who are not pregnant or those without a history of preeclampsia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and management of preeclampsia, potentially improving outcomes for mothers and infants.
How similar studies have performed: Previous research has shown promising results in understanding genetic factors in preeclampsia, but this specific approach using CRISPR is relatively novel.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Julian, Colleen Glyde — University of Colorado Denver
- Study coordinator: Julian, Colleen Glyde
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.